Home › Funds › Opaleye Management Inc. › STOK

Opaleye Management Inc. position in STOK

STOKE THERAPEUTICS INC · Health Care

Opaleye Management Inc. reported holding 700,000 shares of STOK (STOKE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$22.9M, representing 2.07% of its reported portfolio and ranking #13 among its reported holdings. Opaleye Management Inc. has disclosed STOK holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)700.00K sh
Reported value held$22.90M
Portfolio Weight2.07%
First reportedQ4 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Opaleye Management Inc.'s STOK position evolved

Opaleye Management Inc. first disclosed a stake in STOK in Q4 2024 at 25,000 shares (US$276K). The position peaked in Q2 2026 at 700,000 shares, worth US$22.9M. Across 7 filings, Opaleye Management Inc. increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 700,000 shares valued at US$22.9M. Notable position changes include a 1100% increase in Q1 2025 (shares rose 71% over the following quarter), a 87% increase in Q2 2025 (shares rose 107% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 25.00K $275.75K New
Q1 2025 300.00K $2.00M Add
Q2 2025 562.12K $6.38M Add
Q3 2025 682.02K $16.03M Add
Q4 2025 695.00K $22.06M Add
Q1 2026 700.00K $22.79M Add
Q2 2026 700.00K $22.90M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About STOK and 13F data

STOK (STOKE THERAPEUTICS INC) is a Health Care company. 52 other funds we track also report a position in STOK — the largest reported positions include RTW INVESTMENTS, LP (US$184.0M), Lynx1 Capital Management LP (US$132.1M), Redmile Group, LLC (US$129.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding STOK

All STOK fund holders →

FAQ

How long has Opaleye Management Inc. held STOK?

Opaleye Management Inc. has disclosed STOK holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Opaleye Management Inc.'s current position in STOK?

As of Q2 2026, Opaleye Management Inc. holds 700.00K shares of STOK (STOKE THERAPEUTICS INC), valued at $22.90M, representing 2.07% of its reported portfolio and ranking #13.

Has Opaleye Management Inc. been buying or selling STOK?

In the latest 13F filing (Q2 2026), Opaleye Management Inc. held unchanged its position in STOK. The position peaked in Q2 2026 at 700.00K shares.

Which other funds hold STOK?

Other major institutional holders of STOK include RTW INVESTMENTS, LP, Lynx1 Capital Management LP, Redmile Group, LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.